Category: CNS/Neurology
CNS/Neurology market research reports by Roots Analysis
-
Blood Brain Barrier Market (3rd Edition): Industry Trends and Global Forecasts, till 2035
Blood Brain Barrier Market (3rd Edition): Industry Trends and Global Forecasts, till 2035 The Blood Brain Barrier Market is valued at USD 36 million in 2024 growing at a CAGR of 49% during the forecast period 2024-2035. The focus of blood-brain barrier drugs and technologies is to address the challe ... Read More
-
Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered
Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered The Medical Exoskeleton Market is valued at USD 1.90 billion in 2024 growing at a CAGR of 20.8% during the forecast period 2024-2035. Medical exoskeletons, wearable robotic devices tailore ... Read More
-
Alzheimer’s Disease Market: Distribution by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030
Alzheimer’s Disease Market: Distribution by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030 Alzheimer’s disease is a progressive neurological disorde ... Read More
-
Cell and Gene Therapy Bioassay Services Market, 2021-2030
Cell and Gene Therapy Bioassay Services Market, 2021-2030 INTRODUCTION Given the various advantages of cell and gene therapies and their ability to address the underlying causes of serious clinical conditions, the preference for such therapeutic modalities has increased over the years. As a result, ... Read More
-
Cell and Gene Therapy Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare / Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood Disorders, Neurological Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
Cell and Gene Therapy Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare / Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood Disorders, Neurological Disorders, Oph ... Read More
-
Global Autoinjectors Market (4th Edition), 2021-2035 Distribution by Type of Autoinjector (Disposable and Reusable), Route of Administration (Subcutaneous and Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Therapeutic Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts
Global Autoinjectors Market (4th Edition), 2021-2035 Distribution by Type of Autoinjector (Disposable and Reusable), Route of Administration (Subcutaneous and Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Therapeutic Indication (Anaphylaxis, Multiple S ... Read More
-
Site Management Organizations Market by Therapeutic Areas (Oncological Disorders, CNS Disorders, Infectious Diseases, Cardiovascular Diseases and Others), Trial Phase (Phase I, Phase II, Phase III and Phase IV), Clinical Trial Components (Site Management, Onsite Monitoring, Project Management and Others), Type of Interventions (Therapeutics, Devices and Surgical Procedure) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2021-2035
Site Management Organizations Market by Therapeutic Areas (Oncological Disorders, CNS Disorders, Infectious Diseases, Cardiovascular Diseases and Others), Trial Phase (Phase I, Phase II, Phase III and Phase IV), Clinical Trial Components (Site Management, Onsite Monitoring, Project Management and Ot ... Read More
-
SARM1 Targeting Therapeutics Market, 2022-2040
SARM1 Targeting Therapeutics Market, 2022-2040 Neurological disorders are considered the second leading cause of death and the primary cause of long-term disability, worldwide. Across the globe, over 6.5 million neurological disorder related deaths are reported annually. Further, according to a re ... Read More
-
Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035
Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035 Clinical trials form an integral part of the overall drug development process, enabling the necessary evaluation of the safety and efficacy of a drug candidate. As these trials are prone to delays, and can even fail altogethe ... Read More
-
Anti-Aging Therapeutics Market, 2022-2040
Anti-Aging Therapeutics Market, 2022-2040 The advancements in health care and available technologies have inadvertently led to an increase in the life expectancy of individuals. However, this has also led to a rise in the aging population worldwide. According to the United Nations, the aforementione ... Read More
-
Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis Optica and Paroxysmal Nocturnal Hemoglobinuria), Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Oral and Subcutaneous), Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2022-2035
Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis ... Read More
Research Assistance
